Pryor, Cohen drop jawbone on Betaseron price on

WASHINGTON - Senators David Pryor and William Cohen have abandoned, at least for now, their campaign to test the "reasonableness" of the pricing of Betaseron, Chiron Corp.'s new drug for multiple sclerosis.

In an Aug. 30th letter to Berlex Laboratories, Pryor, the Arkansas Democrat who is chairman of the Senate Special Committee on Aging, and Cohen, the Maine Republican who is the committee's ranking minority member, expressed

Read the full 664 word article

How to gain access

Continue reading with a
two-week free trial.